October 16, 2017 | Israeli-based overactive bladder treatment startup Vensica Medical has raised $2 million in a round led by Minnesota-based urology and gynecology device proprietor Cogentix Medical. Cogentix will receive one seat on the Vensica board with options to acquire the entire company for an additional $8 million. Vensica Medical is a private preclinical startup in the process of developing a system to treat overactive bladder (an urgent need to urinate and involuntary loss of bladder control) by using a type of needle-free ultrasound device that will deliver Botox to the bladder using ultrasound technology. Vensica Medical was founded by Avner Geva in 2014.
Subscribe to NoCamels weekly newsletter and get our top stories
Facebook comments